Antineovascular Agents in the Treatment of Eye Diseases
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2645-2660
Author(s):
Wolfram Eichler, Yousef Yafai, Peter Wiedemann and Dorte Fengler
The NK-1 Receptor is Involved in the Antitumoural Action of L-733,060 and in the Mitogenic Action of Substance P on Human Pancreatic Cancer Cell Lines
Journal:
Letters in Drug Design & Discovery
Volume:
3
Page:
323-329
Author(s):
Miguel Munoz, Marisa Rosso and Rafael Covenas
Biological Therapies For Inflammatory Bowel Disease: Research DrivesClinics
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
771-784
Author(s):
Silvio Danese, Stefano Semeraro, Alessandro Armuzzi, Alfredo Papa and Antonio Gasbarrini
Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
835-844
Author(s):
Hiroji Uemura, Hitoshi Ishiguro and Yoshinobu Kubota
Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
1457-1464
Author(s):
Shengguo Sun and Adeboye Adejare
Anti-Cancer/Anti-Tumor
Journal:
Current Bioactive Compounds
Volume:
2
Page:
179-194
Author(s):
Bentham Science Publisher
Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
295-311
Author(s):
Emmanuel A. Ho and Micheline Piquette-Miller
NOTCH Signaling as a Novel Cancer Therapeutic Target
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
313-323
Author(s):
L. Miele, H. Miao and B. J. Nickoloff
Targeted Therapies in Gynecologic Cancers
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
333-363
Author(s):
Hye S. Chon, Wei Hu and John J. Kavanagh
Histone Deacetylase Inhibitors as Potent Modulators of Cellular Contacts
Journal:
Current Drug Targets
Volume:
7
Page:
773-787
Author(s):
Mathieu Vinken, Papeleu Peggy, Rogiers Vera and Vanhaecke Tamara